Literature DB >> 9528657

Site-specific cleavage of tRNA by imidazole and/or primary amine groups bound at the 5'-end of oligodeoxyribonucleotides.

K Ushijima1, H Gouzu, K Hosono, M Shirakawa, K Kagosima, K Takai, H Takaku.   

Abstract

Sequence specific RNA cleaving molecules were synthesized by attaching novel polyamine derivatives bearing imidazole and/or primary amine groups to the 5'-end of DNA oligonucleotides as the sequence-recognizing moieties. The actions of the molecules on a half-tRNA(Asp) were investigated. The oligonucleotides directed the nuclease activity (the imidazole and the primary amine are the catalytic groups) of the enzyme to the nucleotides directly adjacent to the complementary target sequence on the substrate RNA. The cleavage reaction shows a bell-shaped pH dependence with a maximum at pH 7.0, indicating the participation of protonated and non-protonated imidazoles residues in the process. The specificity of these hybrid enzymes can be easily altered, and they should prove to be useful tools for probing RNA structures in solution and as potential reactive groups in antisense oligonucleotide derivatives. We also describe the site-specific cleavage of tRNA(Asp) by the cleaving reagents bearing imidazole and/or primary amine groups at the 5'-end of oligodeoxyribonucleotides.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9528657     DOI: 10.1016/s0304-4165(97)00101-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  9 in total

1.  Artificial ribonucleases: oligonucleotide-peptide conjugates that cleave RNA at the GpX and PypA phosphodiester bonds.

Authors:  N L Mironova; D V Pyshnyi; E M Ivanova; M A Zenkova; G J Gross; V V Vlasov
Journal:  Dokl Biochem Biophys       Date:  2002 Jul-Aug       Impact factor: 0.788

2.  Sequence-specific artificial ribonucleases. I. Bis-imidazole-containing oligonucleotide conjugates prepared using precursor-based strategy.

Authors:  Natalia G Beloglazova; Martin M Fabani; Marina A Zenkova; Elena V Bichenkova; Nikolai N Polushin; Vladimir V Sil'nikov; Kenneth T Douglas; Valentin V Vlassov
Journal:  Nucleic Acids Res       Date:  2004-07-23       Impact factor: 16.971

3.  Covalently attached oligodeoxyribonucleotides induce RNase activity of a short peptide and modulate its base specificity.

Authors:  Nadezhda L Mironova; Dmytryi V Pyshnyi; Eugenya M Ivanova; Marina A Zenkova; Hans J Gross; Valentin V Vlassov
Journal:  Nucleic Acids Res       Date:  2004-03-26       Impact factor: 16.971

4.  Hydrolysis of bulged nucleotides in hybrids formed by RNA and imidazole-derivatized oligo-2'-O-methylribonucleotides.

Authors:  Anthony D Saleh; Paul S Miller
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2011-03       Impact factor: 1.381

5.  Highly efficient catalytic RNA cleavage by the cooperative action of two Cu(II) complexes embodied within an antisense oligonucleotide.

Authors:  Satoshi Sakamoto; Takashi Tamura; Takako Furukawa; Yasuo Komatsu; Eiko Ohtsuka; Masaya Kitamura; Hideo Inoue
Journal:  Nucleic Acids Res       Date:  2003-03-01       Impact factor: 16.971

6.  Site-selective artificial ribonucleases: oligonucleotide conjugates containing multiple imidazole residues in the catalytic domain.

Authors:  Natalia G Beloglazova; Martin M Fabani; Nikolai N Polushin; Vladimir V Sil'nikov; Valentin V Vlassov; Elena V Bichenkova; Marina A Zenkova
Journal:  J Nucleic Acids       Date:  2011-09-25

7.  Selection and cloning of poly(rC)-binding protein 2 and Raf kinase inhibitor protein RNA activators of 2',5'-oligoadenylate synthetase from prostate cancer cells.

Authors:  Ross J Molinaro; Babal Kant Jha; Krishnamurthy Malathi; Sooryanarayana Varambally; Arul M Chinnaiyan; Robert H Silverman
Journal:  Nucleic Acids Res       Date:  2006-12-01       Impact factor: 16.971

8.  RNase T1 mimicking artificial ribonuclease.

Authors:  N L Mironova; D V Pyshnyi; D V Shtadler; A A Fedorova; V V Vlassov; M A Zenkova
Journal:  Nucleic Acids Res       Date:  2007-03-27       Impact factor: 16.971

9.  Targeted inhibition of the hepatitis C internal ribosomal entry site genomic RNA with oligonucleotide conjugates.

Authors:  Valérie Guerniou; Reynald Gillet; Fabienne Berrée; Bertrand Carboni; Brice Felden
Journal:  Nucleic Acids Res       Date:  2007-10-05       Impact factor: 16.971

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.